Cystatin C Improves Early Risk Stratification of Patients With...

"Plasma cystatin C level is an accurate marker of renal function and an independent predictor of mortality, suggesting that its measurement can improve early risk stratification of patients with suspected or confirmed non-ST-elevation acute coronary syndrome (ACS), according to the results of a prospective study published in the Oct. 19 issue of Circulation and published online Oct. 11. However, elevated cystatin C levels were found to be positively but not independently associated with risk of subsequent myocardial infarction (MI)."